Antibiotic Resistance Services
Antibiotic resistance is an escalating global crisis, where the spread of drug resistance is outpacing the development of new antibiotics.
Infections due to antibiotic-resistant bacteria are more dangerous for patients and more difficult and expensive to treat. They often require extended hospital stays, additional follow-up doctor visits, and more costly and toxic alternative treatments.
As drug resistant bacteria become more common, so will deaths from life-threatening infections like sepsis, which is the body’s unregulated immune response to a severe bloodstream infection. Antibiotic resistance already causes at least 700,000 deaths a year and is expected to cause over 10 million deaths annually by 2050.
Sepsis: Leading Cause of Death and Most Expensive Hospital Treated Condition in U.S. Hospitals.
- Affects 1.7M adults per year
- Primary cause of 1 in 3 hospital deaths in the US
- In 2013, sepsis was estimated to cost the US $24B in hospital expenses
- Patients diagnosed with sepsis are 8x more likely to die during hospitalization
Early and effective treatment of antibiotic resistant infections has been proven to save lives. However, current technologies cannot provide actionable information quickly enough to enable early, targeted antibiotic treatment.
Day Zero is developing desperately needed diagnostics that rapidly identity pathogens and determine which antibiotics they will be most vulnerable to. This will allow doctors to provide the most effective treatment immediately, putting the brakes on life-threatening infections and saving countless lives.